Navigation Links
Rock Creek Pharmaceuticals Offers International Shipping Options for Anatabloc™
Date:9/27/2011

GLEN ALLEN, Va., Sept. 27, 2011 /PRNewswire/ -- Rock Creek Pharmaceuticals, a subsidiary of Star Scientific, Inc. (NASDAQ: CIGX), has announced the expansion of shipping options for purchases of its dietary supplement, Anatabloc™.  As the company indicated in an August 30 release on the product launch, Anatabloc™ contains the dietary ingredient anatabine citrate.  Anatabine is an alkaloid that is found in a variety of plants in the Solinacea family, including the tobacco plant as well as in eggplant, green peppers and green tomatoes.  Anatabine citrate, combined with Vitamins A and D3, is believed to assist the body in maintaining anti-inflammatory support.  Excess inflammation is linked with a variety of auto-immune conditions that includes thyroid dysfunction, arthritis and Alzheimer's disease.  

(Photo: http://photos.prnewswire.com/prnh/20110830/PH59627 )

(Logo: http://photos.prnewswire.com/prnh/20090317/STARSCIENTIFICLOGO)

On Friday, September 23, capacity for shipments to Canada, the United Kingdom, Australia and New Zealand was launched.  Yesterday, Rock Creek initiated an international shipping process for the following countries around the globe: Italy, Belgium, Israel, Singapore, Ireland, France, Switzerland, Netherlands, South Africa, Argentina, Spain, Norway and Japan. The company indicated that it will continue to explore options for shipping to additional countries during the next quarter that will be based on consumer demand for Anatabloc™. As new countries are added, they will be included in the listing on the product website, which can be found at www.anatabloc.com, or by calling the customer center at 1-800-778-2031.  Paul L. Perito, Rock Creek's Chairman and CEO, commented: "Although the A
'/>"/>

SOURCE Star Scientific, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. First CyberKnife VSI System Installed at Creekside Cancer Care
2. Star Scientific Comments on Roskamp Institutes Plans to Conduct Human Alzheimers Clinical Trials Using a Compound (RCP-006) Developed by Rock Creek Pharmaceuticals, Inc.
3. Rock Creek Pharmaceuticals Discloses Filing of Provisional Patent Application For Isolated Anatabine Isomer
4. Swedish/Mill Creek Emergency Department, Ambulatory Care Center Opens Soon
5. Roskamp Institute Obtains IRB Approval for Multi-Site Human Clinical Trial with Rock Creek Pharmaceutical RCP-006 Compound
6. Rock Creek Pharmaceuticals Discloses Further Anatabine Patent Filing
7. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... Faruqi & Faruqi, LLP, a leading ... fraud at AVEO Pharmaceuticals, Inc. ("AVEO" or the ... ) The investigation focuses on ... securities laws by issuing materially false and/or misleading ... for Tivopath (tivozanib) (titled "TIVO-1").  Specifically, the investigation ...
(Date:5/17/2013)... May 17, 2013  Sorrento Therapeutics, Inc. (OTCBB: ... Advanced Technology Small Business Technology Transfer Research (STTR) ... and Infectious Diseases (NIAID), a division of the ... of novel human antibody therapeutics to combat ... Staph) infections, including methicillin-resistant S. aureus ...
(Date:5/17/2013)... , May 17, 2013  Sony Biotechnology Inc. ("Sony") ... 8-well strip holder and 130um sorting chip.  Sony will also ... on its new SH800 Cell Sorter, the EC800 flow cytometer, ... tutorials at CYTO 2013, which will be held at the ... San Diego, California , from May 20 - ...
Breaking Medicine Technology:Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Delivers New Technology for Science to CYTO 2013 2
(Date:5/18/2013)... Gordon HealthDay Reporter , , FRIDAY, May 17 (HealthDay ... sometimes binge drink, but new research shows that college women ... a weekly basis than are college men. Much ... that,s considered safe on a weekly basis is much lower ... women versus 14 for men. But, there,s good reason for ...
(Date:5/18/2013)... TheBeautyPlace.com answers important questions about the hairloss products ... result of stress, nutrient deficiency or wearing a favorite ... men suffer from male patterned baldness. , ... transplant surgery, but additionally carries a hair care product ... Professional Strength. Their product line is a five-step treatment ...
(Date:5/18/2013)... KY (PRWEB) May 18, 2013 During ... hearing loss should consider the legal protections they have, ... when problems arise with their child’s treatment or hearing ... , Since 1927, the American Speech-Language-Hearing Association has used ... disorders and to promote treatment, such as cochlear implants, ...
(Date:5/18/2013)... The “Sleep Apnea Diagnostic & Therapeutic ... Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] Global ... and studies the major market drivers, restraints, and opportunities ... World. , Browse , 147 ... , 318 pagesand in-depth TOC of ...
(Date:5/18/2013)... Show And Go Training, the culmination of Eric Cressey’s ... is all about is getting results in the fastest amount ... ’s Stan Stevenson, prompting an investigative review. , “ ... system” designed to make you faster, stronger, fitter and trimmer ... in the gym. The training manual and exercise video database ...
Breaking Medicine News(10 mins):Health News:College Women More Prone to Problem Drinking Than Men: Study 2Health News:College Women More Prone to Problem Drinking Than Men: Study 3Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 2Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 3Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2
... May 26, 2011Folic acid supplements given to pregnant and ... their offspring by 64 per cent, a new study ... Kim, a gastroenterologist at St. Michael,s Hospital, adds to ... supplementation during pregnancy and lactation can increase or decrease ...
... HealthDay Reporter , THURSDAY, May 26 (HealthDay ... of babes, but their minds are able to form ... new study suggests. Joined by colleagues across the ... has developed a computational model of preverbal infants, "pure ...
... , THURSDAY, May 26 (HealthDay News) -- Caffeine, a ... nausea, anxiety and depression. Now, new research reveals that caffeine ... pregnant. By analyzing fallopian tubes in mice, researchers found ... from the ovaries through the fallopian tubes and into the ...
... is available in French and Spanish . ... that music therapy combined with other relax techniques based on ... sleep among patients suffering from fibromyalgia. Thus, this therapy enhances ... has shown that these two techniques enhance the well-being and ...
... danger to human populations. Indeed, exposure to nuclear radiation leads ... according to a new study by Hagen Scherb and Kristina ... radiation from atomic bomb testing before the Partial Test Ban ... nuclear facilities, has had a long-term negative effect on the ...
... recently approved by the Food & Drug Administration for the treatment ... of time. A new study shows abiraterone acetate extends the ... by about four months. The study in the May 26, 2011 ... co-authored by Thomas W. Flaig, MD, medical oncologist at the University ...
Cached Medicine News:Health News:Folic acid given to mother rats protects offspring from colon cancer 2Health News:Babies May Perform 'Pure Reasoning,' Study Suggests 2Health News: Caffeine May Interfere With Fertility in Women 2Health News:Music therapy relieves fibromyalgia symptoms and improves patients' quality of life 2Health News:Nuclear radiation affects baby gender 2Health News:New drug treatment extends lives of men with prostate cancer 2
... The new Finnpipette Focus from ... to combine ergonomics with uncompromising ... handle plate offers a custom ... The new shorter tip cones ...
Inquire...
... 2000 Pipette is a synonym for pipetting ... robust design, and superior operating comfort. Its ... the measuring stroke and blow-out as well ... system ensures utmost accuracy and precision. Ejection ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Medicine Products: